(Date:3/15/2010)... YORK , March 15 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: NBS ... and China , announced,today a change for the Company,s presentation at the ... 15, 2010 .,NeoStem,s presentation will now take place at 10:30 a.m. Pacific ... ... ...
(Date:3/15/2010)... YORK , March 15 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... improving health through the development, manufacture and,commercialization of a broad range of ... fourth quarter and fiscal,year ended December 31, 2009 . ,, ... ... ...
(Date:3/14/2010)... , March 14 /PRNewswire/ -- Results from a landmark study involving more than 9,000 people showed that the high blood ... condition. , ... , , ... ... ...
(Date:3/12/2010)... Vermillion, Inc. (Pink Sheets: VRML) today announced that Medicare will ... mass is benign or malignant. Highmark Medicare Services is the CMS contractor ... to cover this new service. , ... ... ...
Breaking Biology Technology:NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 2NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 3American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 2American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 3American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 4American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 5American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 6American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 7American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 8American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 9American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 10American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 11American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 12NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 2NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 3NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 4NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 5NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 6NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 7NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 8NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 9NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 10NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 11NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 12NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 13Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 2Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 3Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 4... MannKind Corporation (Nasdaq: MNKD ), focused on ... announced today that it will present at the 11th ... on Monday, February 9, 2009 at 2:15 PM (EST) ... In addition to this presentation, the Company ...
... genetic materialSAN DIEGO, Feb. 2 Following three years ... veterans today announced the formation of SG Biofuels ... in the development of Jatropha as a low-cost, sustainably ... Chief Executive Officer, introduced the company at the 2009 ...
... To highlight its 20 years of experience as ... ( www.microtestlabs.com ) is offering free microbial identification ... tests, to eligible attendees visiting the Microtest exhibit, #828, ... highlight Microtest,s wide range of laboratory testing and validation ...
Other Biology Technology:MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference 2Energy, Biotechnology and Agribusiness Veterans Form SG Biofuels to Develop Jatropha as Low-Cost, Sustainable Oil 2Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees 2... has successfully protected mice and ferrets against a highly ... led the study at St. Jude Children's Research Hospital. ... Diego, California. , This finding, coupled with results of ... strains, suggests that such a vaccine would protect humans ...
... To study the bacteria which survive in extreme cold, ... such as Antarctic lakes and glaciers. Bacteria previously isolated ... to survive in extreme cold, have been isolated from ... her colleagues at Queen's University, Canada, have developed a ...
... that generate the strongest immune response in mice, ... a vaccine that significantly protects immunized animals from ... most common cause of hospital-acquired infections and a ... The vaccine protected mice against potentially lethal infections ...
Other Biology News:St. Jude test of bird flu vaccine proves successful 2MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3... Re-Blot Western Blot Recycling Kit is ... Western blots that have been developed ... other isotopes. It is not recommended ... 4-chloronapthol, etc.), as it is not ...
... Immulon ... surface to provide increased binding affinity ... Flat bottom works well for ... optical characteristics., Each ...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
... relax positively and negatively supercoiled DNA in presence ... Studying the effects of supercoiling on transcription in ... , Determining the degree of supercoiling of ... that differ in length by only one base-pair ...
Biology Products:Biology NavigationMedical Navigation